| Primary |
| Product Used For Unknown Indication |
52.9% |
| Drug Use For Unknown Indication |
11.8% |
| Glaucoma |
11.8% |
| Anxiety |
5.9% |
| Hypersensitivity |
5.9% |
| Pain |
5.9% |
| Prophylaxis |
5.9% |
|
| Anaemia |
33.3% |
| Hallucination |
33.3% |
| Rash |
33.3% |
|
| Secondary |
| Product Used For Unknown Indication |
44.8% |
| Acute Coronary Syndrome |
11.6% |
| Interstitial Lung Disease |
7.2% |
| Drug Use For Unknown Indication |
5.5% |
| Fluid Replacement |
3.3% |
| Postpartum Haemorrhage |
3.3% |
| Hypertension |
2.8% |
| Anticoagulant Therapy |
2.2% |
| Pain |
2.2% |
| Cardiac Failure |
1.7% |
| Citrobacter Infection |
1.7% |
| Deep Vein Thrombosis |
1.7% |
| Dyslipidaemia |
1.7% |
| Glaucoma |
1.7% |
| Influenza Like Illness |
1.7% |
| Lung Disorder |
1.7% |
| Stress Ulcer |
1.7% |
| Systemic Lupus Erythematosus |
1.7% |
| Arrhythmia |
1.1% |
| Cardiac Flutter |
1.1% |
|
| Renal Failure Acute |
10.3% |
| Shock Haemorrhagic |
10.3% |
| Subdural Haematoma |
10.3% |
| Thrombocytopenia |
7.7% |
| Pancreatitis |
5.1% |
| Rash Morbilliform |
5.1% |
| Rectal Haemorrhage |
5.1% |
| Renal Tubular Necrosis |
5.1% |
| Somnolence |
5.1% |
| Splenic Haemorrhage |
5.1% |
| Telangiectasia |
5.1% |
| Ventricular Tachycardia |
5.1% |
| Acute Promyelocytic Leukaemia |
2.6% |
| Cholestasis |
2.6% |
| Gastric Ulcer Haemorrhage |
2.6% |
| Generalised Erythema |
2.6% |
| Hallucination |
2.6% |
| Hepatitis Cholestatic |
2.6% |
| Incoherent |
2.6% |
| Jaundice |
2.6% |
|
| Concomitant |
| Product Used For Unknown Indication |
40.2% |
| Plasma Cell Myeloma |
13.5% |
| Hypertension |
7.1% |
| Prophylaxis |
6.1% |
| Thrombosis Prophylaxis |
4.9% |
| Drug Use For Unknown Indication |
4.4% |
| Hiv Infection |
3.6% |
| Infection Prophylaxis |
2.1% |
| Multiple Myeloma |
2.1% |
| Small Cell Lung Cancer |
2.0% |
| Cardiac Failure Chronic |
1.8% |
| Coronary Artery Disease |
1.6% |
| Myocardial Infarction |
1.5% |
| Rheumatoid Arthritis |
1.5% |
| Angina Unstable |
1.3% |
| Diabetes Mellitus |
1.3% |
| Non-small Cell Lung Cancer Stage Iv |
1.3% |
| Pneumonia |
1.3% |
| Headache |
1.1% |
| Hypercholesterolaemia |
1.1% |
|
| Plasma Cell Myeloma |
13.9% |
| Renal Failure Acute |
10.1% |
| Thrombocytopenia |
7.6% |
| Vomiting |
7.6% |
| Pancytopenia |
5.1% |
| Rash Maculo-papular |
5.1% |
| Transient Ischaemic Attack |
5.1% |
| Diarrhoea |
3.8% |
| Myocardial Infarction |
3.8% |
| Pain In Extremity |
3.8% |
| Pyrexia |
3.8% |
| Renal Failure |
3.8% |
| Rhabdomyolysis |
3.8% |
| Sepsis |
3.8% |
| Somnolence |
3.8% |
| Tubulointerstitial Nephritis |
3.8% |
| White Blood Cell Count Decreased |
3.8% |
| Hepatitis Acute |
2.5% |
| Interstitial Lung Disease |
2.5% |
| Liver Transplant |
2.5% |
|
| Interacting |
| Acute Coronary Syndrome |
36.4% |
| Atrial Fibrillation |
27.3% |
| Product Used For Unknown Indication |
27.3% |
| Arthritis |
9.1% |
|
| Gingival Bleeding |
25.0% |
| Intestinal Ulcer |
25.0% |
| Puncture Site Haemorrhage |
25.0% |
| Renal Failure Acute |
25.0% |
|
